Elacestrant
ONA-XR-104
Phase 2 small_molecule terminated
Quick answer
Elacestrant for Breast Cancer is a Phase 2 program (small_molecule) at Context Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Context Therapeutics
- Indication
- Breast Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated